Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × nintedanib × Sarcoma × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 5 Other solid neoplasm 2 Gynecologic 2 Sarcoma 1 Gastrointestinal 1 Breast 1

Conditions

Interventions

Cyclophosphamide 25 Temozolomide 23 Doxorubicin 22 Radiotherapy 21 Filgrastim 19 Ifosfamide 15 Etoposide 13 pazopanib 12 Gemcitabine 12 Cisplatin 12 Irinotecan 11 Imatinib Mesylate 11 Granulocyte Colony-Stimulating Factor 11 Carboplatin 11 Bevacizumab 11 Radiation 9 Magnetic Resonance Spectroscopy 9 fludarabine phosphate 8 Rituximab 8 Methotrexate 8 Docetaxel 8 Cyclosporine 8 Busulfan 8 Antilymphocyte Serum 8 pembrolizumab 7 fludarabine 7 Vincristine 7 Radiotherapy, Intensity-Modulated 7 Mycophenolic Acid 7 Melphalan 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02808247 2021-09-20

ANITA

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡